Clinical Trials Logo

Filter by:
NCT ID: NCT01399593 Terminated - Clinical trials for Antibody Mediated Rejection

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Start date: November 2, 2011
Phase: Phase 2
Study type: Interventional

The purpose of this trial was to determine the safety and efficacy of eculizumab in the prevention of antibody-mediated rejection (AMR) in sensitized recipients of a living donor kidney transplant requiring desensitization therapy.

NCT ID: NCT01399541 Completed - Depression Clinical Trials

Recovery and Rehabilitation After Lung Cancer Surgery

Start date: October 2010
Phase:
Study type: Observational

The specific aims of this translational, interdisciplinary, multi-center, international research study with 300 Lung cancer patients are to: Aim 1 Explore how the patients experience the transfer between different locations and between different levels of care at the same location and how they experienced coming home. Aim 2 Explore lung cancer patients' symptoms, symptom clusters, and changes in symptoms and symptom clusters over time. Aim 3 Explore interaction between lung cancers patients' symptoms, symptom clusters, health related quality of life and social support.

NCT ID: NCT01398917 Recruiting - Clinical trials for Primary Sclerosing Cholangitis

Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis

Start date: May 2011
Phase: Phase 3
Study type: Interventional

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the biliary tract of unknown origin. Around 50% of patients develop during their disease course narrowing of the main bile duct with corresponding increase in symptoms such as itching, jaundice and abdominal pain. These narrowings can be treated by balloon dilatation or temporary insertion of a plastic endoprosthesis. However, it is not known which of these two therapeutic modalities is best. This study aims to compare both techniques in order to determine which is best in terms of postponing recurrence of the narrowing, safety and costs.

NCT ID: NCT01397864 Recruiting - Clinical trials for Hereditary Angioedema

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Start date: July 2011
Phase:
Study type: Observational

This is a non-interventional treatment Registry of Hereditary Angioedema (HAE) patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (rhC1INH / Ruconest), to observe adverse events and insufficient efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest.

NCT ID: NCT01397526 Completed - Clinical trials for Heart Defects, Congenital

Colloid Osmotic Pressure During Heart Surgery in Children

Start date: July 2011
Phase: N/A
Study type: Observational

Clinical oedema is seen after open heart surgery with the use of cardiopulmonary bypass and hypothermia in children. The oedema formation is due to increased fluid transport from blood to tissue. This transcapillary fluid transport is dependent on differences in interstitial and plasma colloid osmotic pressure. The purpose of this investigation is to evaluate changes in interstitial colloid osmotic pressure before, under and after the use of cardiopulmonary bypass in children. The study hypothesis is that oedema developed during cardiopulmonary bypass and hypothermia is caused by increased micro vascular protein leakage and reduced colloid osmotic pressure gradient through the capillary membrane.

NCT ID: NCT01397097 Completed - Contraception Clinical Trials

LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study

Start date: September 2011
Phase: Phase 3
Study type: Interventional

The primary objective is to demonstrate that discontinuation rates in women (ages 18-35 years inclusive) using LCS12 are not higher than those seen in women using ENG subdermal implant over a period of 12 months. Secondary objectives are to observe the bleeding patterns, adverse event profiles and the occurrence of unintended pregnancies. Additionally, data on user satisfaction, IUS expulsions and implant site complications will be collected.

NCT ID: NCT01396226 Completed - Arrhythmia Clinical Trials

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

Start date: September 2011
Phase: Phase 2
Study type: Interventional

Medical Products Agency

NCT ID: NCT01395888 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD

Start date: June 30, 2011
Phase: Phase 3
Study type: Interventional

This study is designed to evaluate the effect of fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder once daily (QD) on arterial stiffness compared with Tiotropium QD over 12 week treatment period in subjects with COPD and aortic pulse wave velocity (aPWV) > 12.0 m/s at Visit 1. Arterial stiffness will be measured as aPWV. This is a comparator, randomised, double-blind, double-dummy, parallel group, multi-centre study. Subjects who meet the eligibility criteria at Screening and meet the randomization criteria at the end of a 2-week Run-In period will enter a 12-week treatment period. There will be an approximate 7-day Follow-up period after the treatment period.

NCT ID: NCT01395303 Completed - Stroke Clinical Trials

Polymorphisms in the Vitamin D System and Health

Start date: April 2011
Phase: N/A
Study type: Observational

Polymorphisms in the vitamin D system appear to affect the serum 25(OH)D levels. If so one would expect these polymorphisms to be associated with vitamin D related conditions and diseases, which will be tested in the present study including DNA analyses in 9700 subjects

NCT ID: NCT01395290 Completed - Infection Clinical Trials

Vitamin D and Staphylococcus Aureus in the Diabetes Study

Start date: April 2011
Phase: Phase 3
Study type: Interventional

There are indications that the vitamin D status of an individual is related to susceptibility to staphylococcal infections. In the present study we will examine nasal colonisation rate in subjects participating in an ongoing vitamin D intervention study ( 20.000 IU cholecalciferol per week vs placebo) for the prevention of type 2 diabetes in subjects with impaired glucose tolerance.